Social Media

Dr. Jean-Christophe EICHER - Cardiologist, University Hospital of DijonCardiac amyloidosis across the spectrum of left ventricular function: multimodal functional…

Join us at  for a specialized scientific meeting focused on the latest updates in the diagnosis and management of Cardiac Amyloidosis.15 May 2026Crowne Plaza…

Brief SummaryCardiac amyloidosis is a progressive disorder caused by extracellular deposition of amyloid fibrils in the heart, leading to heart failure and impaired…

New #CardioOnc Webinar | 'Novel Therapies in AL Amyloidosis', this Thursday https://www.radcliffecardiology.com/.../novel-therapies...Don’t miss out on this in…

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that is notoriously difficult to diagnose. Often mistaken for more…

As #HeartFailure26 begins, perspectives from across the field are shaping how we think about transthyretin #amyloidosis with cardiomyopathy (ATTR-CM). Dr.…

Transthyretin Amyloid Cardiomyopathy (ATTR-CM) is a progressive, life-threatening condition that is notoriously difficult to diagnose. Often mistaken for more…

Cardiac Amyloidosis is a rare but serious condition where abnormal proteins called "Amyloid" accumulate in the heart muscle. This buildup causes the heart walls to…

May is also Ehlers-Danlos Syndromes Awareness Month, which makes sharing this story feel even more meaningful to me. 💜A year ago, I was fighting for answers while…

May 8th is National Amyloidosis Day, a day to raise awareness of this serious and often under-recognised disease.Amyloidosis occurs when abnormal proteins build up…